ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,215Medicare Part D Prescriptions Filled, Including Refills

Rank: 40 out of 1383

$1.24M Total Retail Price of All Prescriptions

Rank: 34 out of 1383

731 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 731 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

25% of this provider’s 731 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 16,395 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
LISINOPRIL 877 628 1 3
OMEPRAZOLE 720 558 2 5
FUROSEMIDE 666 494 3 7
HYDROCODONE-ACETAMINOPHEN 657 417 S3 4 1
METOPROLOL TARTRATE 526 392 5 9
WARFARIN SODIUM 523 338 6 13
POTASSIUM CHLORIDE 491 374 7 12
METFORMIN HCL 478 355 8 8
LEVOTHYROXINE SODIUM 470 370 9 4
SIMVASTATIN 466 380 10 2
DIVALPROEX SODIUM 466 337 10 78
HYDROCHLOROTHIAZIDE 399 316 12 10
MELOXICAM 361 272 13 20
GABAPENTIN 361 163 13 11
DONEPEZIL HCL 346 309 15 35
AMLODIPINE BESYLATE 337 259 16 6
NAMENDA 276 269 17 49
CITALOPRAM HBR 271 178 18 15
TRAMADOL HCL 246 167 19 25
ZOLPIDEM TARTRATE 242 153 20 17
DIGOXIN 218 182 21 59
RANITIDINE HCL 212 170 22 19
PROMETHAZINE HCL 208 94 R 23 56
CARVEDILOL 193 161 24 24
SERTRALINE HCL 192 125 25 21
CLOPIDOGREL 191 156 26 28
ALLOPURINOL 188 178 27 33
CYMBALTA 173 59 28 53
LYRICA 169 94 29 72
FLUOXETINE HCL 168 91 30 52
METFORMIN HCL ER 166 155 31 47
TAMSULOSIN HCL 160 139 32 30
NITROFURANTOIN 156 110 33 187
CLONIDINE HCL 148 135 34 44
CRESTOR 147 128 35 34
PLAVIX 142 131 36 43
CLOZAPINE 142 73 36 291
FAMOTIDINE 133 110 38 61
KLOR-CON 8 132 103 39 242
QUETIAPINE FUMARATE 131 108 40 70
LOSARTAN POTASSIUM 130 114 41 23
LANTUS 126 56 42 50
PREDNISONE 122 101 43 40
LOVASTATIN 120 82 44 22
DIOVAN 119 107 45 58
RAMIPRIL 116 92 46 80
VENTOLIN HFA 115 62 47 93
CIPROFLOXACIN HCL 115 88 47 54
LISINOPRIL-HYDROCHLOROTHIAZIDE 112 100 49 27
ATENOLOL 111 103 50 16
DICLOFENAC SODIUM 109 65 51 114
EVISTA 106 83 52 152
TORSEMIDE 105 68 53 183
TRAZODONE HCL 103 61 54 36
LEVOFLOXACIN 103 73 54 88
ROPINIROLE HCL 99 86 56 79
OXYCODONE HCL-ACETAMINOPHEN 99 0 S2 56 81
FLUTICASONE PROPIONATE 96 68 58 39
DILTIAZEM 24HR CD 96 77 58 95
SEROQUEL 95 79 60 130
OXYBUTYNIN CHLORIDE 95 47 60 115
PAROXETINE HCL 94 56 62 55
CELEBREX 92 80 63 131
ALENDRONATE SODIUM 91 53 64 37
PANTOPRAZOLE SODIUM 90 59 65 32
GLIPIZIDE 88 76 66 98
NEXIUM 86 54 67 26
EXELON 86 86 67 117
GLYBURIDE 86 80 R 67 46
SPIRIVA 85 61 70 45
AZITHROMYCIN 85 68 70 41
AMITRIPTYLINE HCL 85 54 R 70 57
CEPHALEXIN 85 60 70 87
PROPRANOLOL HCL 84 67 74 129
FLUCONAZOLE 82 34 75 136
DILTIAZEM 24HR ER 80 57 76 161
ADVAIR DISKUS 79 49 77 63
ESTRADIOL 79 50 R 77 96
LEVETIRACETAM 78 33 79 134
IPRATROPIUM-ALBUTEROL 78 72 79 138
CARBIDOPA-LEVODOPA 78 70 79 108
BENAZEPRIL HCL 77 53 82 38
ISOSORBIDE MONONITRATE ER 77 66 82 66
POLYETHYLENE GLYCOL 3350 77 63 82 64
NOVOLOG 76 16 85 139
SULFAMETHOXAZOLE-TRIMETHOPRIM 76 52 85 89
PROAIR HFA 76 29 85 42
LACTULOSE 75 69 88 128
METOCLOPRAMIDE HCL 73 32 89 127
MEGESTROL ACETATE 73 71 R 89 170
KLOR-CON M20 73 67 89 100
COMBIVENT 72 33 92 116
RISPERIDONE 70 46 93 71
ESCITALOPRAM OXALATE 70 56 93 99
TRICOR 69 41 95 125
PREMARIN 68 48 R 96 123
CARISOPRODOL 67 13 R 97 76
MECLIZINE HCL 67 63 97 113
MIRTAZAPINE 67 46 97 51
CYCLOBENZAPRINE HCL 66 29 R 100 69
BUSPIRONE HCL 66 11 100 109
METOLAZONE 66 63 100 221
HYDRALAZINE HCL 65 49 103 86
VERAPAMIL ER 65 43 103 84
DIOVAN HCT 64 53 105 103
ABILIFY 64 36 105 178
PRIMIDONE 64 54 105 207
OLANZAPINE 63 54 108 164
QUINAPRIL HCL 61 43 109 142
SUBOXONE 61 0 109 135
PHENYTOIN SODIUM EXTENDED 59 12 111 137
PRAVASTATIN SODIUM 57 49 112 14
ATORVASTATIN CALCIUM 56 28 113 18
DILTIAZEM ER 56 51 113 110
CEFTRIAXONE 55 26 115 175
JANUVIA 54 43 116 85
AMLODIPINE BESYLATE-BENAZEPRIL 53 53 117 68
FENTANYL 53 22 S2 117 92
KLOR-CON 10 53 50 117 74
SPIRONOLACTONE 52 37 120 67
SODIUM CHLORIDE 51 22 121 263
DILTIAZEM HCL 51 50 121 203
AGGRENOX 50 44 123 191
NYSTATIN 50 39 123 132
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 10, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.